Amjevita® (adalimumab-atto)
for Ulcerative Colitis

Amjevita (adalimumab-atto) is a biosimilar to Humira, a tumor necrosis factor (TNF) alpha blocker used to treat autoimmune conditions. It helps reduce pain, inflammation, and skin symptoms. Amjevita is approved for treating rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ulcerative Colitis - UC